Literature DB >> 2649133

Continuous, hyperfractionated, accelerated radiotherapy (CHART).

S Dische1, M I Saunders.   

Abstract

Mesh：

Year:  1989        PMID： 2649133      PMCID： PMC2247093          DOI： 10.1038/bjc.1989.64

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  16 in total

1.  Radiotherapy employing three fractions on each of twelve consecutive days.

Authors:  M I Saunders; S Dische; J F Fowler; J Denekamp; E P Dunphy; E Grosch; D Fermont; R Ashford; J Maher; C Des Rochers
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

2.  A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.

Authors:  A C Begg; N J McNally; D C Shrieve; H Kärcher
Journal:  Cytometry       Date:  1985-11

3.  Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences.

Authors:  G Peracchia; C Salti
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-01       Impact factor: 7.038

4.  What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation?

Authors:  K R Trott; J Kummermehr
Journal:  Radiother Oncol       Date:  1985-01       Impact factor: 6.280

5.  The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.

Authors:  G D Wilson; N J McNally; E Dunphy; H Kärcher; R Pfragner
Journal:  Cytometry       Date:  1985-11

6.  The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).

Authors:  W Van den Bogaert; E van der Schueren; J C Horiot; G Chaplain; G Arcangeli; D Gonzalez; V Svoboda
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-10       Impact factor: 7.038

Review 7.  Cell kinetics and radiation biology.

Authors:  J Denekamp
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1986-02

8.  Twice-a-day radiation therapy for supraglottic carcinoma.

Authors:  C C Wang; H D Suit; P H Blitzer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-01       Impact factor: 7.038

9.  Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy.

Authors:  C Schaake-Koning; L Schuster-Uitterhoeve; G Hart; D Gonzalez Gonzalez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-07       Impact factor: 7.038

10.  Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used?

Authors:  J F Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038
View more
  10 in total

Review 1.  Surgical excision alone is adequate treatment for primary colorectal cancer.

Authors:  R Hind; D R Rew; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

2.  Advances in cell kinetics.

Authors:  D A Rew; G D Wilson
Journal:  BMJ       Date:  1991-09-07

3.  A meta-analysis comparing hyperfractionated vs. conventional fractionated radiotherapy in non-small cell lung cancer.

Authors:  Weisan Zhang; Qian Liu; Xifeng Dong; Ping Lei
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

4.  Cell proliferation, tumour growth and clinical outcome: gains and losses in intestinal cancer.

Authors:  D A Rew
Journal:  Ann R Coll Surg Engl       Date:  1993-11       Impact factor: 1.891

5.  Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy.

Authors:  Patrick Beauchesne; Valerie Bernier; Charlotte Carnin; Luc Taillandier; Mohamed Djabri; Laurent Martin; Xavier Michel; Jean-Philippe Maire; Toufic Khalil; Christine Kerr; Thierry Gorlia; Roger Stupp; Remy Pedeux
Journal:  Neuro Oncol       Date:  2010-02-11       Impact factor: 12.300

Review 6.  Lung cancer--still a long road ahead.

Authors:  N M Bleehen
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

7.  Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity.

Authors:  Martin Turzer; Odd Terje Brustugun; Einar Waldeland; Aslaug Helland
Journal:  Case Rep Oncol       Date:  2011-01-21

8.  Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.

Authors:  R Palmqvist; A Oberg; C Bergström; J N Rutegård; B Zackrisson; R Stenling
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

9.  Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

10.  An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.